Moreover, researchers found that RHOJ can also regulate tumor invasion in breast cancer,1 melanoma4 and glioblastoma,5 providing a direction for a new line of clinical translational research on targeting RHOJ for inhibiting tumor invasion in cancer therapy. The gene discussed is RHOJ; the disease is breast carcinoma.